Drugmakers Hold Back Swiss Reimbursement Applications Amid Pricing Concerns

Pharmaceutical companies are increasingly delaying applications for health-insurance reimbursement for new medicines in Switzerland, raising concerns about patient access to innovative treatments. A survey by Swiss pharmaceutical industry association Interpharma found that seven of 22 innovative medicines introduced between January 2025 and June 2026 were not submitted for inclusion on Switzerland’s mandatory health-insurance reimbursement list. […]

Continue Reading

AbbVie

Company Profile About AbbVie AbbVie is a global biopharmaceutical company focused on discovering, developing and delivering medicines for a range of serious and chronic health conditions. The company became an independent publicly traded company in 2013 following its separation from Abbott, while retaining a connection to Abbott’s long pharmaceutical heritage. AbbVie’s portfolio and research activities […]

Continue Reading

Novartis

Company Profile About Novartis Novartis is a global innovative medicines company headquartered in Basel, Switzerland. The company was established in 1996 through the merger of Ciba-Geigy and Sandoz, creating one of the world’s major research-based pharmaceutical organizations. Novartis focuses on discovering and developing medicines intended to address significant disease burdens. Its principal research and therapeutic […]

Continue Reading